ENTRY       D00538                      Drug
NAME        Zonisamide (JP18/USP/INN);
            Excegran (TN)
PRODUCT     ZONEGRAN (Concordia Pharmaceuticals)
            ZONISADE (Azurity Phramaceuticals)
  GENERIC   ZONISAMIDE (American Health Packaging)
            ZONISAMIDE (Aurobindo Pharma Limited)
            ZONISAMIDE (AvPAK)
            ZONISAMIDE (BluePoint Laboratories)
            ZONISAMIDE (Bryant Ranch Prepack)
            ZONISAMIDE (Bryant Ranch Prepack)
            ZONISAMIDE (Bryant Ranch Prepack)
            ZONISAMIDE (Bryant Ranch Prepack)
            ZONISAMIDE (Cipla USA)
            ZONISAMIDE (Direct_Rx)
            ZONISAMIDE (Direct_Rx)
            ZONISAMIDE (Exelan Pharmaceuticals)
            ZONISAMIDE (Glenmark Pharmaceuticals)
            ZONISAMIDE (NCS HealthCare of KY)
            ZONISAMIDE (Preferred Pharmaceuticals)
            ZONISAMIDE (Proficient Rx LP)
            ZONISAMIDE (Proficient Rx LP)
            ZONISAMIDE (Proficient Rx LP)
            ZONISAMIDE (Quality Care Products LLC)
            ZONISAMIDE (REMEDYREPACK)
            ZONISAMIDE (REMEDYREPACK)
            ZONISAMIDE (Sun Pharmaceutical Industries)
            ZONISAMIDE (Unichem Pharmaceuticals (USA))
            ZONISAMIDE (Viona Pharmaceuticals)
            ZONISAMIDE (Zydus Lifesciences Limited)
FORMULA     C8H8N2O3S
EXACT_MASS  212.0256
MOL_WEIGHT  212.2257
CLASS       Cardiovascular agent
             DG01575  Calcium channel blocker
              DG01573  Calcium channel T type blocker
            Neuropsychiatric agent
             DG03199  Antiepileptic agent
            Metabolizing enzyme substrate
             DG01633  CYP3A/CYP3A4 substrate
REMARK      Same as: C07504
            Therapeutic category: 1139 1169
            ATC code: N03AX15
            Product: D00538<JP/US>
EFFICACY    Anticonvulsant, Antiepileptic
COMMENT     Benzisoxazole derivative
TARGET      SCN1A [HSA:6323] [KO:K04833]
            SCN2A [HSA:6326] [KO:K04834]
            SCN3A [HSA:6328] [KO:K04836]
            SCN4A [HSA:6329] [KO:K04837]
            SCN5A [HSA:6331] [KO:K04838]
            SCN8A [HSA:6334] [KO:K04840]
            SCN9A [HSA:6335] [KO:K04841]
            SCN10A [HSA:6336] [KO:K04842]
            SCN11A [HSA:11280] [KO:K04843]
            CACNA1-T [HSA:8911 8912 8913] [KO:K04856 K04855 K04854]
  PATHWAY   hsa04010(8911+8912+8913)  MAPK signaling pathway
            hsa04020(8911+8912+8913)  Calcium signaling pathway
            hsa04728(6323)  Dopaminergic synapse
METABOLISM  Enzyme: CYP3A [HSA:1576 1577 1551]
INTERACTION  
STR_MAP     map07033  Anticonvulsants
            map07057  Antiparkinsonian agents
            map07231  Sodium channel blocking drugs
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             N NERVOUS SYSTEM
              N03 ANTIEPILEPTICS
               N03A ANTIEPILEPTICS
                N03AX Other antiepileptics
                 N03AX15 Zonisamide
                  D00538  Zonisamide (JP18/USP/INN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Anticonvulsants
              Sodium Channel Agents
               Zonisamide
                D00538  Zonisamide (JP18/USP/INN)
            Therapeutic category of drugs in Japan [BR:br08301]
             1  Agents affecting nervous system and sensory organs
              11  Agents affecting central nervous system
               113  Antiepileptics
                1139  Others
                 D00538  Zonisamide (JP18/USP/INN)
               116  Antiparkinsonian agents
                1169  Others
                 D00538  Zonisamide (JP18/USP/INN)
            Drug groups [BR:br08330]
             Cardiovascular agent
              DG01575  Calcium channel blocker
               DG01573  Calcium channel T type blocker
                D00538  Zonisamide
             Neuropsychiatric agent
              DG03199  Antiepileptic agent
               D00538  Zonisamide
             Metabolizing enzyme substrate
              DG01633  CYP3A/CYP3A4 substrate
               D00538  Zonisamide
            Drug classes [BR:br08332]
             Neuropsychiatric agent
              DG03199  Antiepileptic agent
               D00538  Zonisamide
            Target-based classification of drugs [BR:br08310]
             Ion channels
              Voltage-gated ion channels
               Sodium channels
                SCN1A
                 D00538  Zonisamide (JP18/USP/INN) &lt;JP/US&gt;
                SCN2A
                 D00538  Zonisamide (JP18/USP/INN) &lt;JP/US&gt;
                SCN3A
                 D00538  Zonisamide (JP18/USP/INN) &lt;JP/US&gt;
                SCN4A
                 D00538  Zonisamide (JP18/USP/INN) &lt;JP/US&gt;
                SCN5A
                 D00538  Zonisamide (JP18/USP/INN) &lt;JP/US&gt;
                SCN8A
                 D00538  Zonisamide (JP18/USP/INN) &lt;JP/US&gt;
                SCN9A
                 D00538  Zonisamide (JP18/USP/INN) &lt;JP/US&gt;
                SCN10A
                 D00538  Zonisamide (JP18/USP/INN) &lt;JP/US&gt;
                SCN11A
                 D00538  Zonisamide (JP18/USP/INN) &lt;JP/US&gt;
               Calcium channels
                CACNA1-T
                 D00538  Zonisamide (JP18/USP/INN) &lt;JP/US&gt;
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D00538  Zonisamide
              D00538  Zonisamide tablets
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D00538
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D00538
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D00538
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D00538
DBLINKS     CAS: 68291-97-4
            PubChem: 7847604
            ChEBI: 10127
            PDB-CCD: ZON
            LigandBox: D00538
            NIKKAJI: J20.559A
ATOM        14
            1   C8y C    23.2246  -18.0420
            2   C8y C    24.5519  -17.6112
            3   C8y C    23.2246  -19.4447
            4   C8x C    22.0139  -17.3435
            5   N5x N    25.3783  -18.7462
            6   O2x O    24.5576  -19.8813
            7   C8x C    22.0139  -20.1433
            8   C8x C    20.7973  -18.0420
            9   C8x C    20.7973  -19.4447
            10  C1b C    24.5519  -16.2112
            11  S4a S    25.7651  -15.5107
            12  O3c O    26.9775  -14.8107
            13  N1a N    25.0763  -14.3183
            14  O3c O    26.4767  -16.7426
BOND        15
            1     1   2 1
            2     1   3 2
            3     1   4 1
            4     2   5 2
            5     3   6 1
            6     3   7 1
            7     4   8 2
            8     7   9 2
            9     5   6 1
            10    8   9 1
            11    2  10 1
            12   10  11 1
            13   11  12 2
            14   11  13 1
            15   11  14 2
///
